The lung is a major barrier surface that interfaces with the environment and is often prone to infection. A highly coordinated immune response protects the respiratory tract from pathogens and other external insults. The role of the nervous system in regulating pulmonary host defense is not well defined. Pulmonary infections and lethal pneumonia are major public-health problems frequently causing death in children and immunocompromised and elderly people 1 . S. aureus is a Gram-positive human bacterial pathogen that is the leading cause of hospital-acquired infections, particularly respiratory-tract infections and ventilator-associated pneumonia [1] [2] [3] [4] . The increased prevalence of multidrug-resistant bacteria including methicillin-resistant S. aureus (MRSA) strains necessitates nonantibiotic approaches to treatment. Targeting neuroimmunological signaling may be a novel approach to boost host immunity against lung pathogens.
The lung is a major barrier surface that interfaces with the environment and is often prone to infection. A highly coordinated immune response protects the respiratory tract from pathogens and other external insults. The role of the nervous system in regulating pulmonary host defense is not well defined. Pulmonary infections and lethal pneumonia are major public-health problems frequently causing death in children and immunocompromised and elderly people 1 . S. aureus is a Gram-positive human bacterial pathogen that is the leading cause of hospital-acquired infections, particularly respiratory-tract infections and ventilator-associated pneumonia [1] [2] [3] [4] . The increased prevalence of multidrug-resistant bacteria including methicillin-resistant S. aureus (MRSA) strains necessitates nonantibiotic approaches to treatment. Targeting neuroimmunological signaling may be a novel approach to boost host immunity against lung pathogens.
The trachea, bronchi, and airways are innervated by peripheral sensory afferents originating from vagal and spinal sensory neurons, whose cell bodies reside within the vagal ganglia (VG) and dorsal root ganglia (DRG), respectively [5] [6] [7] . Nociceptor neurons are the subset of these neurons that respond to noxious stimuli including heat, protons, ATP, mechanical injury, inflammation, and chemical irritants 8 . Upon activation, nociceptors induce pain, coughing, and bronchoconstriction 5, [8] [9] [10] . Recent work has shown that nociceptors cross-talk with immune cells in the respiratory tract, thereby driving allergic responses and bronchoconstriction in mouse models of asthma 5, 11, 12 . Here, we investigated a previously unexplored role of sensory neurons in pulmonary host defenses against bacterial invasion and lethal pneumonia.
RESULTS

TRPV1 + neurons mediate survival and bacterial clearance in pneumonia
We hypothesized that lung-innervating nociceptors are poised to detect bacterial invasion and to coordinate pulmonary immunity. The Transient receptor potential vanilloid 1 (TRPV1) ion channel responds to capsaicin, protons, and heat stimuli 8, 13 . TRPV1 is expressed by many C fibers, including nociceptors that mediate thermal nociception and inflammatory hyperalgesia [14] [15] [16] . TRPV1 + neurons have been found to drive allergic airway hypersensitivity 5 .
We first used a genetic approach to determine the role of TRPV1 + neurons in host defense 5, 16 . Trpv1-Dtr mice express the human diphtheria-toxin receptor (DTR) under control of mouse TRPV1 regulatory sequences 16 . Mouse cells are normally resistant to diphtheria toxin (DT)-induced apoptosis but are rendered susceptible by expression of DTR. We performed daily injections of DT into 5-to 7-week old Trpv1-Dtr mice to selectively ablate TRPV1 + neurons 5, 16 . DT treatment, compared with PBS treatment, significantly ablated TRPV1 + neurons in both the DRG and VG in Trpv1-Dtr mice ( Supplementary  Fig. 1 ). CGRP is expressed by many peptidergic C-fiber nociceptors 16, 17 . There were significantly fewer CGRP + neurons in DTtreated Trpv1-Dtr mice than in PBS-treated controls ( Supplementary  Fig. 1 ). In contrast, the proportion of NF-200 + neurons, which include A fibers, was higher in the DT-treated Trpv1-Dtr mice. In DT-treated compared with PBS-treated Trpv1-Dtr mice, we also observed a loss of CGRP + nerves around the airways (Supplementary Fig. 2 ) and a r t i c l e s 4 1 8 VOLUME 24 | NUMBER 4 | APRIL 2018 nature medicine decreased noxious-heat responses in hot-plate and tail-flick assays ( Supplementary Fig. 3 ). Next, we asked whether TRPV1 + neurons might affect pulmonary host defenses. Trpv1-Dtr mice recovered 7 d after DT or PBS treatment and were subsequently intratracheally inoculated with a lethal dose of the MRSA strain USA300 (1.3 × 10 8 to 1.4 × 10 8 colony-forming units (CFU); Fig. 1a ). Trpv1-Dtr mice treated with DT, compared with those treated with PBS, showed significantly longer survival and better maintenance of core body temperature after MRSA pneumonia (Fig. 1b) . DT-treated Trpv1-Dtr mice, compared with PBS-treated controls, also exhibited tenfold-lower bacterial burdens recovered from lungs at 12 h postinfection (Fig. 1c) .
We used Resiniferatoxin (RTX) as a second strategy to target TRPV1 + neurons. RTX is a high-affinity TRPV1 ligand that can be used to chemically denervate and ablate nociceptors 15, 18 . Mice were subcutaneously treated with RTX at 4 weeks of age for consecutive days with escalating doses (30, 70 , and 100 µg/kg) according to established protocols 19, 20 . RTX-treated mice, compared with vehicle-treated mice, showed increased latency to noxious heat in hot-plate and tailflick assays, and loss of TRPV1 + and CGRP + neurons in the DRG and VG ( Supplementary Figs. 3 and 4) . At 4 weeks after RTX injection, mice were intratracheally inoculated with MRSA (0.8 × 10 8 to 1 × 10 8 CFU; Fig. 1d ). Whereas most vehicle-treated mice succumbed to pneumonia (80% mortality), most RTX-treated mice survived (Fig. 1e) . RTX-treated mice, compared with vehicle-treated mice, showed improved maintenance of core body temperature (Fig. 1e) and less lung bacterial burden (Fig. 1f) . Trpv1-Dtr-mediated ablation and RTX treatment enhanced protection in mice infected with a sublethal dose of S. aureus (2 × 10 7 to 4 × 10 7 CFU), as measured by bacterial-load recovery (Supplementary Fig. 5 ). Because nociceptors may regulate the peripheral resistance of the cardiovascular and pulmonary systems to infection, we measured vital signs. However, the oxygen saturation, heart rate, perfusion, and respiratory rates did not differ between RTXtreated and vehicle-treated mice at steady state; the respiratory rates also did not differ postinfection (Supplementary Fig. 6 ).
Next, we asked whether nociceptors might modulate host defense against bacterial pathogens other than S. aureus. RTX-treated and vehicle-treated mice were infected with lethal doses of Streptococcus pneumoniae, Klebsiella pneumoniae, or Pseudomonas aeruginosa. The RTX-treated mice and vehicle-treated mice showed similar decreases in core body temperature after infection with the three pathogens ( Supplementary Fig. 7) . Nociceptor deficiency showed a modest but nonsignificant protective effect (P = 0.13) in survival during S. pneumoniae infection (Supplementary Fig. 7 ). Nociceptor deficiency did not affect death caused by K. pneumoniae or P. aeruginosa pneumonia (Supplementary Fig. 7 ).
Nav1.8 is a voltage-gated sodium channel expressed by a large subset of nociceptors that overlap with but are distinct from TRPV1 + neurons 16, 21 . Nav1.8-cre +/− mice were bred with diphtheria toxin A (DTA) reporter mice to generate animals deficient in Nav1.8-lineage neurons (Nav1.8-Cre +/− ; Dta) 21 . After MRSA infection, we observed a trend toward higher survival (P = 0.09) and lower bacterial burden (P = 0.07) in Nav1.8-Cre +/− ; Dta mice than in control littermates (Supplementary Fig. 8 ). However, the beneficial effects of Nav1.8-lineage neuron ablation (Supplementary Fig. 8 ) were considerably smaller than those observed for TRPV1 neuron ablation (Fig. 1) .
TRPV1 ion channel does not mediate pulmonary host defense
We next determined whether the TRPV1 ion channel itself was involved in host defense. Trpv1 −/− mice have previously been found to have exaggerated physiologic responses in a model of polymicrobial sepsis 22 . After S. aureus lung infection, we did not observe Left, survival curves of PBS-treated Trpv1-Dtr mice (n = 11) and DT-treated Trpv1-Dtr mice (n = 13). Log-rank (Mantel-Cox) test (P = 0.01). Right, measurements of core body temperature (temp.) over time in PBStreated (n = 7) and DT-treated Trpv1-Dtr mice (n = 8). Two-way repeated (RM) analysis of variance (ANOVA) with Bonferroni post tests (***P = 0.001; *P = 0.014). (c) Lung bacterial burdens 12 h after infection in PBS-treated (n = 13) and DT-treated Trpv1-Dtr mice (n = 12). Two-tailed unpaired t test (P = 0.0042). (d) Resiniferatoxin (RTX)-mediated chemical ablation of TRPV1 + neurons. WT mice 4 weeks of age were injected subcutaneously daily with three escalating doses of RTX or vehicle. Mice were rested for 4 weeks before intratracheal inoculation with S. aureus USA300 (0.8 × 10 8 to 1 × 10 8 CFU/mouse). (e) Left, survival curves of vehicle-treated (n = 20) and RTX-treated mice (n = 18). Log-rank test (P < 0.0001). Right, core-bodytemperature measurements in vehicle-treated (n = 5) and RTX-treated mice (n = 5). Two-way RM ANOVA with Bonferroni post tests (****P < 0.001).
(f) Lung bacterial-load recovery 12 h after S. aureus infection in vehicle-treated (n = 13) and RTX-treated mice (n = 13). Two-tailed unpaired t tests (P = 0.0035). Data were pooled from two (b) or three (c,e,f) independent experiments. Data are shown as mean ± s.e.m. (b,e, core body temperature) and mean (c,f). a r t i c l e s nature medicine VOLUME 24 | NUMBER 4 | APRIL 2018 4 1 9 significant differences in survival, core-body-temperature measurements, or lung bacterial burdens in Trpv1 −/− mice compared with Trpv1 +/− or Trpv1 +/+ control littermates (Supplementary Fig. 9 ). The postinfection induction of cytokines (IL-17A, IL-6, and IL-23) in lung lysates of Trpv1 −/− mice was similar to that in control littermates ( Supplementary Fig. 10 ). We also examined the role of TRPA1, which mediates airway inflammation in a mouse model of asthma 11 . Trpa1 −/− mice, compared with Trpa1 +/+ littermates, did not show differences in bacterial burdens after lethal or sublethal S. aureus infection ( Supplementary Fig. 11 ).
TRPV1 and Nav1.8 neurons regulate bacterial dissemination We next determined whether nociceptors mediated the spread of bacterial pathogens from the lung to extrapulmonary sites. DT-treated Trpv1-Dtr mice showed higher numbers of bacteria in the blood (P = 0.01) after lethal MRSA infection than did controls ( Supplementary  Fig. 12 ). RTX-treated mice also showed greater blood dissemination than did vehicle-treated controls (Supplementary Fig. 12 ).
At a sublethal dose of infection, both Trpv1-Dtr ablation and RTX treatment increased MRSA dissemination to the blood and spleen (Supplementary Fig. 13 ). In Nav1.8-Cre +/− ; Dta mice, compared with control littermates, we also observed significantly greater bacterial dissemination to the blood, which was accompanied by greater spleen size (Supplementary Fig. 13 ). We investigated whether nociceptor ablation affected lung-barrier permeability. RTX-treated mice, compared with vehicle-treated mice, showed greater leakage of fluorescein isothiocyanate (FITC)-dextran to the blood after intratracheal inoculation, thus suggesting a role of nociceptors in maintaining barrier integrity (Supplementary Fig. 14) .
TRPV1 neurons regulate lung inflammation and cytokine induction
We performed histological analysis of lungs at different time points to analyze pulmonary inflammation after S. aureus infection. RTXtreated mice, compared with vehicle-treated mice, showed greater immune-cell influx in the lungs at 12 h and 24 h postinfection, as determined by H&E staining (Fig. 2a) . We hypothesized that early increases in immune cells might correlate with improved bacterial clearance in RTX-treated mice. Brown and Brenn staining showed many Gram-positive bacterial colonies in vehicle-treated lungs at 12 h and 24 h postinfection (Fig. 2b) . In contrast, RTX-treated mice showed few bacterial colonies (Fig. 2b) . We next determined whether nociceptors regulated proinflammatory-cytokine production. At an early time point of infection (6 h), RTX-treated mice showed higher induction of total inflammatory-protein levels in the bronchoalveolar lavage fluid (BALF) (Fig. 2c) , as well as levels of the cytokines TNF-α and IL-6, and the chemokine CXCL-1 (Fig. 2d) . By 12 h postinfection, TNF-α, IL-6, and CXCL-1 levels were lower in RTX-treated mice (Fig. 2d) , as were levels of the cytokines IL-1β and MCP-1 ( Supplementary Fig. 15 ). These data indicated that TRPV1 + neuron ablation leads to faster induction and resolution of cytokine levels during infection. . Vehicle-treated group, 0 h (n = 6), 2 h (n = 8), 6 h (n = 8), 12 h (n = 9); RTX-treated group, 0 h (n = 6), 2 h (n = 7), 6 h (n = 6), 12 h (n = 10). Two-way RM ANOVA with Bonferroni post tests (****P < 0.001).
(d) Levels of IL-6, TNF-α, and CXCL-1 in BALF from mice at different time points after S. aureus infection (1 × 10 8 CFU/mouse). TNF-α: vehicletreated group, 0 h (n = 6), 2 h (n = 10), 6 h (n = 10), 12 h (n = 10); RTX-treated group, 0 h (n = 6), 2 h (n = 7), 6 h (n = 6), 12 h (n = 10). IL-6: vehicle-treated group, 0 h (n = 6), 2 h (n = 10), 6 h (n = 10), 12 h (n = 10); RTX-treated group, 0 h (n = 6), 2 h (n = 7), 6 h (n = 6), 12 h (n = 10). CXCL-1: vehicle-treated group, 0 h (n = 6), 2 h (n = 8), 6 h (n = 8), 12 h (n = 10); RTX-treated group, 0 h (n = 6), 2 h (n = 7), 6 h (n = 6), 12 h (n = 10). Statistical analysis for all cytokines by two-way RM ANOVA with Bonferroni post tests (**P = 0.0013; ****P < 0.0001). Data from one experiment with multiple biological replicates are shown in a and b; data pooled from two independent experiments are shown in c and d. Data are shown as mean ± s.e.m. in c and d. a r t i c l e s TRPV1 neurons suppress recruitment of neutrophils We next used FACS analysis to analyze the kinetics of immunecell influx into inflamed lungs during S. aureus infection. RTXtreated mice, compared with vehicle-treated mice, displayed greater CD11b + Ly6G + lung neutrophil recruitment at 6 h and 12 h postinfection (Fig. 3a,b) . Trpv1-Dtr-neuron-ablated mice showed greater neutrophil recruitment than did PBS-treated controls at 12 h postinfection (Fig. 3c) . Because neutrophils are critical for bacterial clearance 23 , we hypothesized that neuronal modulation of neutrophil recruitment might play a major role in MRSA pneumonia. We depleted neutrophils in RTX-treated mice by using low-dose anti-GR1 antibody treatment, which, compared with control IgG treatment, eliminated CD11b + Ly6G + neutrophils in infected lungs (Fig. 3d) . Anti-GR1 also decreased CD11b + Ly6C hi monocytes but did not affect CD11b + Ly6C lo monocytes (Supplementary Fig. 16 ). Neutrophil depletion in RTX-treated mice significantly increased their susceptibility to MRSA pneumonia: whereas 100% of anti-GR1-treated RTX mice succumbed to infection, 0% of the control IgG-treated RTX mice died from infection (Fig. 3e) . These experimental results were confirmed in an independent cohort of mice ( Supplementary  Fig. 17 ). Neutrophils were also required for baseline protection against MRSA pneumonia (Fig. 3e) . These data suggested that RTXmediated enhancement of lung immunity requires neutrophils.
TRPV1 neurons regulate pulmonary neutrophil surveillance Within lungs, neutrophils perform endothelial and parenchymal surveillance for pathogens 24, 25 . Using intravital microscopy, we analyzed the subpleural vascular bed to assess whether neutrophil kinetics and patrolling of tissues were regulated by nociceptors. Compared with control mice, RTX-treated mice recruited significantly more neutrophils to pulmonary capillaries during early S. aureus pneumonia (Fig. 4a,b and Supplementary Video 1) . We observed less GFP-S. aureus in the lungs of nociceptor-depleted animals, in agreement with previous CFU data. Dynamic neutrophil behavioral phenotypes were analyzed for tethering, crawling, and firm adhesion within the vasculature. Tethering is a rapid, transient neutrophil interaction with the vessel wall, which requires limited cellular activation. Adhesion indicates a more advanced state of activation mediated by integrins before tissue emigration. Crawling is a complex intravascular behavior that requires upregulation of β2-integrin, which occurs rapidly during lung host defense 24, 25 . Neutrophils behaved differently during host defense in control versus RTX-treated mice. In RTX-treated mice, a significant proportion of neutrophils demonstrated vascular crawling (Fig. 4c) , and tracking individual pulmonary vascular neutrophils revealed significantly greater crawling distances (Fig. 4d,e) , a phenotype consistent with cellular activation and host defense against bacterial pathogens. Therefore, live imaging supports the contention that enhanced neutrophil function in the absence of nociceptors aids in the eradication of bacterial pneumonia.
Nociceptor neurons regulate lung-resident gd T cells
We next asked whether TRPV1 + neurons might alter the lungresident immune-cell populations in naive mice, thus setting the stage for subsequent inflammatory responses. We first examined immunological-transcriptome data sets at the Immunological Genome Project (http://www.immgen.org/) and found that Trpv1 expression was absent across immune-cell types (Supplementary Fig. 18 ). Analysis of a second transcriptional data set 26 showed that Trpv1 was absent in immune cells but was highly expressed in DRG (Supplementary Fig. 18 ). We next purified CD4 + T cells, B cells, neutrophils, and γδ T cells from mouse lungs, and performed quantitative PCR analysis for Trpv1 compared with that in sensory ganglia. Whereas Trpv1 was highly expressed in the VG and DRG, it was undetectable in all lung immune cells analyzed ( Supplementary Figs. 19 and 20) . These data indicated that Trpv1-Dtr or RTX-mediated ablation should specifically target nociceptors but should not have direct effects on immune cells. We examined spleens of RTX-treated and vehicle-treated mice and did not observe differences in the populations of B220 + B cells, NK1.1 + cells, CD4 + T cells, CD8 + T cells, or γδ T cells; moreover, Trpv1-Dtr-neuronablated mice showed similar results ( Supplementary Fig. 21 ).
We next examined whether lung-resident immune-cell types differed in nociceptor-ablated mice at steady state. Fig. 22 and Fig. 5a ). B cells, natural killer cells, and CD8 + T cells also did not differ; however, CD4 + T cells were slightly higher in RTX-treated mice than in controls ( Supplementary Fig. 23 and Fig. 5b ).
We observed higher absolute numbers of lung-resident γδ T cells, in contrast to most other immune-cell types, in RTX-treated mice compared with vehicle-treated mice (Fig. 5c) . Further subset analysis revealed that this increase was specific to Vγ1 + cells and Vγ1 − Vγ2 − cells, but not Vγ2 + cells ( Fig. 5c and Supplementary Figs. 24 and 25). We found a similar increase in γδ T cells in Nav1.8-Cre +/− ; Dta mice compared with control littermates (Supplementary Fig. 24 ). γδ T cells reside within epithelial layers of the lungs, skin, and gut, where they act as first responders to infection 27 . We next used γδ T cell-deficient Tcrd −/− mice to investigate the role of these cells in neuroimmunological suppression. Wild-type (WT) or Tcrd −/− mice were treated with RTX to ablate TRPV1 + neurons, and then S. aureus pneumonia was induced (Fig. 5d,e) . The absence of γδ T cells was confirmed in Tcrd −/− mice through flow cytometry (Fig. 5d) . Tcrd deficiency led to a loss of protection against MRSA infection and abrogated the survival enhancement due to RTX treatment (Fig. 5e ). This reversal of protective immunity correlated with an imbalance in core body temperature ( Fig. 5e ) and greater bacterial burdens in BALF isolated from RTX-treated Tcrd −/− mice compared with RTX-treated WT mice ( Supplementary Fig. 26 ). Tcrd −/− also showed defective baseline immunity against MRSA pneumonia (Fig. 5e) . Whereas IL-6 levels were unaffected by Tcrd deficiency, levels of IL17A, a cytokine mediating protection against MRSA 28 , were significantly lower in Tcrd −/− mice (Supplementary Fig. 26 ). Neutrophil recruitment did Fig. 26 ), thus suggesting that γδ T cells and neutrophils are separately regulated.
We next determined whether alveolar macrophages mediated neuronal regulation of the host defense (Fig. 5g) . Mice were intratracheally instilled with clodronate-laden liposomes (CLL) to kill alveolar macrophages through phagocytosis-dependent apoptosis. PBSencapsulated liposomes (PBS-L) were used as a control treatment. CLL treatment specifically eliminated alveolar macrophages (SiglecF + CD11c + CD64 + F4/80 + ) but not interstitial macrophages or dendritic cells ( Fig. 5f and Supplementary Fig. 27 ). Alveolar-macrophage depletion did not alter the greater survival or core-body-temperature maintenance of RTX-treated compared with vehicle-treated mice (Fig. 5g) . Together, our results suggested that the RTX-treatmentmediated enhancement of MRSA immunity requires both γδ T cells and neutrophils but not alveolar macrophages.
Ablation of vagal TRPV1 neurons improves host defense
The vagus nerve provides the major source of sensory innervation of the lung. The cell bodies of vagal afferents reside in fused ganglia at the base of the skull, controlling coughing, breathing, and bronchoconstriction 5, 6 . Our previous experimental approaches targeted
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Siglec-F-PerCP-Cy5. all TRPV1 + cells, including both DRG and VG neurons. We hypothesized that vagal TRPV1 + neurons might include the subset regulating neuroimmunological suppression. To specifically target these neurons, we performed bilateral intraganglionic DT injections into the VG in 5-to 9-week-old Trpv1-Dtr mice. Immunostaining showed that vagal but not DRG TRPV1 + neurons were specifically ablated ( Fig. 6a and Supplementary Fig. 28 ). Vagal TRPV1 + neuron ablation did not alter the heart rate, oxygen saturation, perfusion, or respiratory rate (Supplementary Fig. 6 ). Mice were rested 2 weeks after intraganglionic injections, then infected with a lethal dose of MRSA. We observed a striking survival benefit in vagal DT-injected Trpv1-Dtr mice compared with vagal PBS-injected mice, and better maintenance of core body -treated (n = 19) mice. Log-rank test, P = 0.03. Right, core body temperature of PBS-treated (n = 12) and CGRP -treated (n = 11) mice. Two-way RM ANOVA with Bonferroni post tests (**P = 0.002 (16 h); **P = 0.004 (24 h)). One experiment was performed with multiple biological replicates for a, d, and f; two independent experiments were performed for b, c, and e; three independent experiments were performed for g. (Fig. 6b) . All mice from the PBS-injected group died within 72 h after infection, whereas a 90% survival rate was observed among mice lacking vagal TRPV1 neurons (Fig. 6b) . The greater survival in vagal DT-treated mice correlated with higher neutrophil recruitment and lower lung bacterial burdens (Supplementary Fig. 29 ).
Nociceptive neuropeptide CGRP modulates lung antimicrobial defense Nociceptor neurons actively communicate with the immune system through their release of neuropeptides stored within peripheral nerve terminals 29 . The nociceptive neuropeptide CGRP inhibits TNF-α production in macrophages and suppresses lymph node hypertrophy in skin bacterial infection 29, 30 . We hypothesized that CGRP might mediate neuroimmunological signaling during lethal bacterial pneumonia. We found that CGRP levels significantly increased in the BALF after S. aureus infection (Fig. 6c) . Infection with an S. aureus strain mutant for agr, a key bicomponent quorum-sensing regulator of virulence-factor expression 31 , did not induce CGRP release into the BALF (Fig. 6c) . S. aureus also directly induced cultured neuronal release of CGRP in vitro, in a manner dependent on agr (Supplementary Fig. 30 ). TRPV1 + cells mediated CGRP release in the lungs, because CGRP levels were significantly lower in the BALF in RTX-treated and vagal DT-treated Trpv1-Dtr mice than in control-infected mice at 12 h postinfection (Fig. 6d) . CGRP levels were also significantly lower in the BALF at steady state in nociceptor-depleted mice than in control nondepleted mice (Supplementary Fig. 31) .
We next asked whether CGRP might play a role in MRSA pneumonia. Quantitative PCR analysis showed that lung γδ T cells and neutrophils expressed Ramp1 and Calcrl, which encode the cognate CGRP receptor (Supplementary Fig. 32 ). We found that CGRP treatment inhibited lung-cell production of TNF-α and CXCL1, but not IL-6, in response to MRSA infection (Fig. 6e) . Increasing concentrations of CGRP also inhibited intracellular killing of S. aureus by mouse neutrophils (Supplementary Fig. 33 ). To explore the involvement of CGRP in host defense, we treated mice with the competitive CGRP peptide antagonist CGRP at time points before and after S. aureus lung infection (Fig. 6f) . This treatment, compared with vehicle treatment, improved survival and core-body-temperature maintenance (Fig. 6f) . We next found that CGRP 8-37 administered at time points after S. aureus infection also significantly improved survival and core-body-temperature maintenance (Fig. 6g) . These data showed that nociceptors mediate CGRP release during lung infections and that postinfection blockade of CGRP signaling may aid in treatment of bacterial pneumonia.
DISCUSSION
Nociceptor neurons and immune cells play key roles in protecting organisms from environmental dangers. It is potentially advantageous that interactions between these cell types coordinate host responses to pathogen invasion. We found that TRPV1 + afferents in the VG played a critical role in modulating innate immune responses against MRSA lethal pneumonia. Targeting these neurons through Trpv1-Dtr-mediated ablation (or RTX treatment) improved survival, neutrophil and γδ T cell responses, and bacterial clearance. Nav1.8-cre; Dta mice, in which an overlapping though distinct nociceptor subset is targeted, showed a milder protective phenotype. Both strategies paradoxically resulted in increased bacterial dissemination. These data suggested that differences in phenotypes (lung clearance versus barrier function) are mediated by distinct neuronal subsets. A recent study has shown that Trpv1 expression in the adult DRG is mainly restricted to CGRP + and substance P (SP) + C fibers 14 . In contrast, Nav1.8 has been found to be expressed in myelinated A fibers as well as C fibers 32 . Another study has shown that Nav1.8-Cre; Dta mice still possess CGRP + neurons expressing TRPV1 (ref. 21) . Therefore, future experiments using more refined genetic tools should help to distinguish the functional contributions of individual TRPV1 + and/or Nav1.8 + neuronal subsets in pulmonary immunity and barrier function.
Our work adds to recent studies showing major physiological roles for neuroimmunological interactions at peripheral barrier tissues 33 . In the respiratory tract, nociceptors actively cross-talk with immune cells, thereby mediating allergic airway inflammation 5, 11, 12 . Skininnervating nociceptors drive inflammation and immunological activation in mouse models of psoriasis 20 and contact dermatitis 34 . In the gut, sympathetic neurons regulate macrophage tissue programming at homeostasis and during Salmonella infection 35 .
We found that nociceptors suppressed pulmonary γδ T cell-and neutrophil-mediated host defense during MRSA lung infections. A recent study has found that nociceptors drive dendritic-cell IL-23 production and γδ T cell activation during skin invasion by the fungal pathogen Candida albicans 19 . The observed phenotypic difference in that study compared with our study is interesting, because differential interactions of vagal versus somatosensory sensory neurons may occur with immune-cell types at different barrier sites. Diverse γδ T cell populations seed mucosal and epithelial sites 27 . In the skin, epidermal γδ T cells are mostly Vγ5 + cells that mediate barrier integrity, whereas dermal γδ T cells do not express Vγ5, but ~40% of them are Vγ4 + and are involved primarily in IL-17A production 36 . IL-17 production by γδ T cells has also been found to mediate host defense against S. aureus skin infections 28, 37 . Heterogeneous subsets of γδ T cells are found in the respiratory tract, including Vγ1 + , Vγ2 + , and Vγ6 + populations 38 .
It is striking that vagal sensory afferents, which comprise fewer than 5,000 neurons, are able to potently regulate antimicrobial immunity. Distinct vagal afferents control physiological functions including breathing and nutrient sensation 6, 39 . It would be interesting to ascertain how neuronal subsets differentially cross-talk with immune cells. Immune cells may utilize nerves as tracts for migration, as has been observed for dendritic-cell interactions with Nav1.8 + nociceptors in the skin 20 . Lung-resident immune cells may be proximal to vagal nerve afferents and may consequently able to set up local neuroimmunological responses. Recently, the neuropeptide NMU has been found to drive ILC2-mediated inflammation in the gut and lungs [40] [41] [42] . We found that nociceptors released the neuropeptide CGRP into the airways during infection and downregulated immunity. CGRP has previously been linked to vasodilation and vascular permeability 43 . CGRP suppresses CXCL1, an important chemokine for lung-neutrophil chemoattraction 44 . Furthermore, CGRP antagonism improves survival outcomes in MRSA-infected mice and is therefore a potential target for clinical application in pneumonia.
Notably, other mechanisms beside CGRP signaling could mediate nociceptor immunological signaling. Nociceptors release glutamate, ATP, and other neuropeptides including SP, neurokinin A, and VIP. They also upregulate cytokines including CCL2 (ref. 45 ) and CSF-1 after nerve injury 46 . Vagal afferents may also induce sensoriautonomic neuroimmunological reflexes including a 'cholinergic antiinflammatory reflex' , which acts through vagal autonomic efferents and downregulates peripheral macrophage TNF-α production 47 .
The role of nociceptors in host defense may vary depending on the type of pathogenic invasion. Whereas increased neutrophil influx confers host protection against MRSA pneumonia, the same responses could lead to immunopathology in other infections. For example, influenza virus and severe acute respiratory syndrome coronavirusa r t i c l e s nature medicine VOLUME 24 | NUMBER 4 | APRIL 2018 4 2 5
cause pathology through overactivation of lung inflammation 48, 49 . In pneumonia caused by K. pneumoniae, Escherichia coli, and S. pneumoniae, bacterial dissemination is a primary cause of sepsis and mortality 50, 51 . For MRSA-induced pneumonia, lethality is mainly mediated by damage to the lungs by secreted exotoxins (Hla and PVL) rather than bacterial dissemination 3, 52 . These differences in bacterial pathogenesis may explain our observed differences in responses to distinct pathogens in nociceptor-ablated mice. Our study demonstrates that nociceptors play a critical role in regulating pulmonary immunity and the outcomes of bacterial lung infections. Targeting neuroimmunological communication through CGRP or other molecular mechanisms may be an effective approach to enhance host protection against pneumonia.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 16 were provided by M. Hoon (NIH). Nav1.8-cre mice 21 were originally from J. Wood (University College London). Nav1.8-cre +/− mice were bred with B6.Dta +/+ mice to generate Nav1.8-cre +/− ; Dta mice and control littermates (Nav1.8-cre −/− ; Dta). For Trpv1 and Trpa1 experiments, heterozygous mice were bred to produce WT, heterozygous, and knockout littermates. Age-matched 8-to 14-week-old male and female mice were used for experiments.
Bacterial strains and cultures. The MRSA strain USA300/LAC 53 was provided by M. Otto (NIH). For infection, USA300/LAC was grown overnight (O/N) at 37 °C in tryptic soy broth (TSB, Sigma) at 250 r.p.m. and was subcultured at a 1:100 dilution for 3.5 h in TSB to mid-log phase. K. pneumoniae strain 43816 serotype 2 was purchased from American Type Culture Collection and was grown O/N at 37 °C in TSB at 250 r.p.m. for infection. S. pneumoniae WU-2 strain from R. Malley (Boston Children's Hospital) was grown at 37 °C under 5% CO 2 without shaking for 18 h in Todd's Hewitt broth (THB, Sigma) with 0.5% yeast extract and was subcultured at a 1:10 dilution for 8 h in fresh THB with 0.5% yeast extract to reach mid-log phase for infection. P. aeruginosa strain PA01V from G. Pier (Brigham and Women's Hospital) was grown O/N at 37 °C in TSB at 250 r.p.m. and was subcultured at a 1:100 dilution for 4 h in TSB for infection. For all strains, cultures were centrifuged at 5,000 r.p.m. for 5 min, and bacterial pellets were washed and resuspended in phosphate-buffered saline (PBS). The OD 600 was measured to estimate bacterial density, and serial plating was performed on tryptic soy agar (TSA) plates to quantify CFU values. For intravital imaging, a GFP-MRSA S. aureus transgenic bacterium was used, whose construction has been previously reported 25 .
Bacterial lung infections. For all bacterial infections, age-matched 8-to-14-week-old male and female mice, weighing between 19 and 30 g, were studied. For lethal infections, 50 µl containing 0.8 × 10 8 to 1.6 × 10 8 CFU S. aureus in PBS was intratracheally inoculated per mouse. Control animals were intratracheally infused with 50 µl PBS only. For sublethal infections, 2 × 10 7 to 4 × 10 7 CFU of S. aureus was used per mouse. For S. pneumoniae infections, 10 6 CFU in 50 µl PBS was intratracheally inoculated. For K. pneumoniae infections, 10 4 CFU in 50 µl PBS was intratracheally inoculated. For P. aeruginosa infections, 7 × 10 6 CFU in 50 µl PBS was intratracheally inoculated. Mice were monitored twice daily for morbidity and mortality. In some experiments, CGRP 8-37 (Genscript) was administered i.p. at 800 ng (256 pmol) or 7.5 µg (2.4 nmol) per dose in 200 µl PBS, at different time points relative to infection (0 h). Control mice received 200 µl PBS only.
Vital-sign measurements. Heart rate, oxygen saturation, and perfusion were measured under isoflurane anesthesia by Pulse Oximetry with the Kent Scientific PhysioSuite (Kent Scientific Corporation). For accuracy, measurements were performed three independent times on different days for the same mice, and values represent the average of three measurements. Pulse oximetry could not be used on MRSA-infected mice because they could not survive isoflurane anesthesia, and thus the measurements were performed only at steady state. Respiratory rates were determined by manually recording the number of breaths per minute and were averaged over three measurements. Core body temperature was measured with a rectal thermal probe (Bioseb).
Genetic and chemical ablation of TRPV1 + nociceptors. Trpv1-Dtr mice were treated with DT as previously described 5 . Mice were injected i.p. with 200 ng of DT (Sigma Aldrich) dissolved in 100 µl PBS or with 100 µl PBS (vehicle) daily for a 21-d period. 5-to 7-week-old male and female mice were used for these experiments. For chemical ablation of TRPV1 + neurons, C57BL/6 mice 4 weeks of age were treated with RTX (Sigma) as previously described 19, 20 . Mice were injected subcutaneously in the flank on consecutive days with three increasing doses of RTX (30, 70 , and 100 µg/kg) dissolved in 2% DMSO with 0.15% Tween 80 in PBS. Control mice were treated with vehicle alone. For intravital imaging experiments, the same dosage for RTX treatment was used in 4-week-old mice, except the vehicle for dissolution was DMSO (without Tween 80). RTX was diluted into DMSO (1 µg/ìl) and subsequently into saline before injections. For VG -targeted ablation, we performed bilateral intraganglionic injections of DT or PBS into Trpv1-Dtr mice as previously described 5 . 20 ng DT in 120 nl PBS containing 0.05% Fast Green was injected into nodose/jugular/petrosal VG with a nanoinjector (Drummond Scientific Company). Mice were anesthetized with 1-3% isofluorane with oxygen. The vagal ganglion was exposed after a midline incision in the neck (~1.5 cm in length). DT was gently injected; this process was repeated for the vagal ganglion on the other side of the body.
Bronchoalveolar lavage fluid (BALF) analysis.
Mice were euthanized by CO 2 inhalation, and the trachea were exposed and cannulated with a 20-gauge catheter (BD Insyte Autoguard). BALF was collected two times by instilling 0.8 ml of cold PBS containing heparin and dextrose, then centrifuged at 4,000 r.p.m. for 7 min at 4 °C, and the cell pellet was separated from the supernatant. Total BALF leukocytes were counted after red-blood-cell lysis (RBC lysis buffer, eBioscience) and subjected to flow cytometry. Cell-free BALF supernatant was filtered through a 0.22-µm filter and mixed with protease/phosphatase-inhibitor cocktail, then kept at −80 °C for protein and cytokine analysis.
Bacterial-load and cytokine measurements. Lungs and spleen tissues were homogenized in 1 ml sterile water with BB beads (Daisy Outdoor Products) in a Tissue Lyzer II (Qiagen). Lung, spleen homogenates, blood, or BALF was serially diluted in PBS and plated on TSA plates. The bacterial CFU were enumerated after overnight incubation of TSA plates at 37 °C. Cytokine levels in lung homogenates and BALF were measured through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions (Biolegend).
Behavior tests. For behavioral assays, observers were blinded to the treatment group and genotype. To measure heat sensitivity, mice were placed on a hot plate set at 52 °C (IITC Life Science). Latency to hindpaw lifting, licking or flinching was recorded, and stopped at a maximum of 60 s. For tail-flick assays, mice were kept vertically in a relaxed fashion with their tails immersed in a temperature-controlled water bath maintained at 52 °C. The latency to a tail flick was recorded, with a maximum of 60 s.
Immune-cell depletion. For neutrophil depletion, we followed an established protocol 54 . Mice were injected i.p. with 125 µg of anti-GR1 (clone RB6-8C5, BioXCell, NH) (in 200 µl) per mouse 24 h before lung infection. Control mice received 125 µg of rat IgG (Jackson Immunoresearch). For depletion of alveolar macrophages, 100 µl CLL (purchased from http://clodronateliposomes.org/) was delivered intratracheally into mice 2 d before infection. Control mice received an equal volume of PBS-L.
Lung-barrier permeability assay. FITC-dextran (Mol Wt 4,000, Sigma) was intratracheally inoculated in 50 µl/mouse at 20 mg per kg body weight. Control mice were inoculated with PBS. Four hours later, mice were euthanized, and blood was collected by cardiac puncture. Blood was allowed to coagulate for 30 min at room temperature in the dark and centrifuged at 2,500g for 15 min. Fluorescence in serum was recorded with a plate reader (BioTek Synergy) and normalized to FITC-dextran standards (1.56-100 µg/ml). Quantitative real-time PCR. An RNeasy Plus Mini Kit (Qiagen) was used to isolate RNA, which was reverse transcribed to cDNA with an iScript cDNA Synthesis Kit (Bio-Rad). Relative gene expression was determined by quantitative real-time PCR on a ViiA7 System (Thermo Fisher Scientific) with TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific) with the following primer/probe sets: Trpv1 (Mm01246300_m1), Ramp1 (Mm00489796_m1), Calcrl (Mm00516986_m1), and Actb (Applied Biosystems). Expression values relative to Actb (detected in the same sample by duplex qPCR) were calculated.
Neuronal cultures and CGRP analysis. DRG neuron cultures were grown as previously described 30 . In brief, total DRG were dissected from 8-to 12-weekold mice and digested in HEPES-buffered saline (Sigma) containing 1 mg/ml collagenase A and 3 mg/ml dispase II (Roche Applied Sciences) for 60 min at 37 °C. The cell suspension was triturated with fire-polished Pasteur pipettes, then centrifuged over a 12% BSA (Sigma) gradient. The top layer of debris was discarded, and cell pellets were resuspended in neurobasal (NB) medium containing B27 (Life Technologies). Neurons were plated on laminin-coated 96-well culture dishes in NB medium containing B27, 50 ng/ml nerve growth factor (Life Technologies), and penicillin/streptomycin (Life Technologies). The medium was changed every other day. At day 7, DRG neurons were stimulated with S. aureus or 500 nM capsaicin (Sigma) for 30 min, and supernatant was collected. CGRP levels in the culture supernatant, BALF, or lung homogenates were determined with a CGRP EIA kit according to the manufacturer's instructions (Cayman Chemical).
Gene expression analysis. We analyzed transcript levels in mouse transcriptome data sets deposited at the Immunological Genome Project 55 (GEO GSE15907).
Data sets for CD4 + , CD8 + T cells, B cells, γδ T cells, NK cells, macrophages, dendritic cells, and neutrophils were analyzed. Trpv1 expression was also analyzed in the Mouse Gene Atlas MOE430 transcriptome data set 26 (GEO GSE1133). Microarray data were background corrected and normalized with the robust multiarray average (RMA) algorithm in GenePattern (Broad Institute). A heat map for average transcript values was plotted with Morpheus (Broad Institute), Trpv1 levels were also plotted with Prism (GraphPad).
Lung histology. Whole lungs were dissected from mice after euthanasia, fixed and stored in 10% formalin (Sigma Aldrich). Samples were embedded, sectioned, and stained with H&E or with a Brown and Brenn stain for Gram-positive bacteria by the Harvard Rodent Histopathology Core. Light microscopy of histological sections was conducted on a Nikon Ti-E microscope.
Immunofluorescence and microscopy. For immunostaining, mice were perfused with PBS followed by 4% paraformaldehyde (PFA) in PBS. VG and thoracic DRG (T1-T13) were dissected and postfixed for 2 h in 4% PFA/PBS at 4 °C, incubated O/N at 4 °C with 30% sucrose/PBS, embedded in optimal cutting temperature compound (OCT, Tissue-Tek, PA) and stored at −80 °C. 12-µm cryosections were cut and immunostained with the following antibodies: guinea pig anti-TRPV1 (Millipore, AB5566, dilution 1:1,000), rabbit anti-CGRP (Sigma, C8198, dilution 1:5,000), mouse anti-NF-200 (Millipore, MAB5266, dilution 1:1,000), rabbit anti-βIII-tubulin (Tuj1) (Abcam, ab18207, dilution 1:1,000), and mouse anti-βIII-tubulin (Abcam, ab7751, dilution 1:500). Secondary antibodies included DyLight-488 donkey anti-rabbit IgG (Abcam, 1:500), CF-488A goat anti-guinea pig IgG (Sigma, 1:500), Alexa 488 donkey anti-mouse IgG (Abcam, 1:500), Alexa 594 donkey anti-mouse IgG (Abcam, 1:500) and Alexa 594 donkey anti-rabbit IgG (Abcam, 1:500). Sections were mounted in Vectashield and imaged with a Nikon Ti-E microscope with 10× magnification with NIS Elements software (Nikon, version AR3.22.08). For quantification of VG and DRG neuronal populations, images were analyzed by observers blinded to genotypes and treatment groups. β-tubulin-III was used as a general neuronal marker. Multiple fields were captured from three mice per group.
For immunostaining of lung sections, lungs were perfused with cold PBS and gravity inflated with 4% PFA/PBS. After overnight fixation at 4 °C, lungs were incubated 2 d in 30% sucrose/PBS, cryoembedded in OCT, and stored at −80 °C until sectioning. 40-µm cryosections were blocked for 4 h in PBS with 10% donkey serum, 2% bovine serum albumin (BSA), and 0.8% Triton X-100. Sections were incubated with rabbit anti-CGRP (C8198, Sigma) at a 1:5,000 dilution in blocking solution (PBS with 2% donkey serum, 2% BSA, and 0.3% Triton X-100) for 16-18 h at 4 °C, then incubated with secondary antibody (Alexa 594 donkey anti-rabbit IgG H&L, Abcam, ab150076) at a 1:500 dilution in blocking solution at 4 °C. Stained specimens were imaged on an inverted laser scanning confocal microscope (Olympus Fluoview FV1000).
Adobe Photoshop (Adobe) was used to quantify CGRP + airway innervation in lung sections. The lasso tool was used to trace the circumference of each inner lung airway on the basis of DAPI staining; The area enclosed (in pixels) was derived from the histogram tool. The traced circumference was expanded by 162 pixels (100 µm) for each airway. The magic-wand tool was used to select the CGRP + pixels within the circumscribed area and quantified out of the entire airway border, which is the percentage area covered by CGRP + nerve fibers.
Neutrophil isolation and bacterial killing. Mouse bone marrow neutrophils were isolated with an EasySep Mouse Neutrophil Enrichment Kit according to the manufacturer's instructions (StemCell Technologies). A Diff-Quick Stain kit (Thermo scientific) was used to confirm purity, which was found to be >95% neutrophils. To perform bacterial killing assays, 2.5 × 10 5 neutrophils were cocultured with 5 × 10 5 CFU of S. aureus (MOI of 2) in DMEM (Gibco) containing 5% FBS. CGRP (Genescript) was added at different concentrations, and cells were incubated at 37 °C for the indicated times. Neutrophils were then centrifuged at 600 r.p.m. for 2 min, and the pellet was washed twice with PBS and incubated for 30 min with 200 µg/ml gentamicin. Neutrophils were lysed with 0.1% Triton X-100, and dilutions were plated onto TSA plates to measure intracellular, viable bacteria. Lung cells were also isolated from C57BL/6J mice 
Data exclusions
Describe any data exclusions. No data were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
For all lethal and sub-lethal lung bacterial infections, experiments were performed at least twice, and data from individual mice were pooled from all experiments. Similar numbers of mice were used in each experiment in parallel for control and treatment experimental groups. Differences between control and treatment groups or differences between genotypes showed consistent and reproducible results across our study. For in vitro experiments, multiple biological replicates were used for each treatment group. Multiple biological replicates of lung immune cells were purified and sensory ganglia dissected for gene expression analysis. The exact number of independent experiments conducted for each experiment are described in Figure legends. 
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Experiments involving knockout or transgenic mice were carried out across littermates of mixed genotypes (e.g hetrozygous, wild-type or knockout mice) in the same cage that were randomly put together at weaning prior to genotyping. All experiments involving treatments (e.g. RTX vs. vehicle) were performed on equal groups of cagemates or littermates. For infections, the same inoculum of S. aureus, P. aeruginosa, K. pneumoniae, or S. pneumoniae and used to infect across experimental groups in random order to ensure equivalent dosing.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For all lethal and sub-lethal lung bacterial infection experiments in mice, the experimenter measuring survival, temperature, and other parameters was blinded to mouse genotype and treatment groups during infections and post-infection procedures until being unblinded at the analysis stage.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Graphpad Prism software (version 7.0B) was used for statistical analyses of survival data, core body temperature data, bacterial load recovery data, total protein/ cytokine/CGRP measurements, percentage of cells analyzed by FACS, gene expression data, and neutrophil lung surveillance/movement data. All recordings of intravital microscopy videos were processed and analyzed using Leica software and Volocity software (Perkin Elmer). For neutrophil behavior analysis, random neutrophils were tracked manually in 10-min videos by using Volocity software (Perkin Elmer). FlowJo software (Treestar, version 10.0.8r1) was used for all analyses of flow cytometry data. Immunoflurescence and H&E images were collected using Nikon's NIS Elements software (Nikon, version AR3.22.08). Microarray data from GEO datasets (Accession number GSE15907 and GSE1133) was background corrected and normalized using Robust Multi-array Average (RMA) algorithm in the GenePattern software (Broad Institute). A heatmap for average transcript values was plotted using Morpheus software (Broad Institute). Normalized Trpv1 expression levels were plotted using Prism software (Graphpad). Adobe Photoshop (Adobe) was used to quantify CGRP+ nerve staining in lung section images as described in the Methods section. Prism software (Graphpad) was used to plot Kaplan-Meier survival curves, bar graphs, scatter dot plots, and line graphs presented throughout the manuscript. Adobe Illustrator software (Adobe) was used to generate figures in the manuscript.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All bacterial strains, mouse strains and reagents used in the study are either commercially available or will be made readily available with no more restrictive terms than a uniform biological materials transfer agreement (UBMTA). We were generously supplied certain reagents for our study through such agreements, including Trpv1-Dtr mice from Mark Hoon (NIH) and MRSA strain USA300 from Mike Otto (NIH).
(Bectin Dickinson). FACS purification of lung immune cells was accomplished in a BD FACSAria machine (Bectin Dickinson).
7. Describe the software used to collect and analyze the flow cytometry data.
Data were collected with BD DIVA software, and files subsequently analyzed using FlowJo (Treestar, version 10.0.8r1) 8 . Describe the abundance of the relevant cell populations within post-sort fractions.
We FACS purified several subsets of lung immune cells for quantitative realtime PCR, including neutrophils, TCRgd+ T cells, CD4+ T cells and B cells. The exact gating strategies used are given in Supplemental Figure 19. 9. Describe the gating strategy used. For FACS analysis of lung cells and splenocytes: FSC vs. SSC gates were first used to exclude cell debris (bottom and far left) and to include most cells. The live cell stain (eFluor 450, ebioscience) was used to exclude dead cells for BALF and splenocyte analysis. Positive staining and gates for each fluorescent marker was defined by comparing full stainsets with a fluorescence minus one (FMO) control stainset that only lacked a particular marker antibody, but contained the rest of the antibodies in a mixed stain-set cocktail.
For FACS purification of lung cells: Single-cell suspensions were incubated with CD90.2 MicroBeads (Miltenyi Biotec) and separated into CD90.2 positive and negative fractions. Both fractions were stained on ice with surface antibodies, live/dead marker 7AAD and sorted on a BD FACSAria (BD Biosciences). Different cell types were identified by the following gating strategies: B cells (7AAD-CD45+CD19+) and neutrophils (7AAD-CD45+CD11b+Ly6G+) were sorted from the pre-enriched CD90.2-cell fraction, while CD4+ T cells (7AAD-CD45+CD3+TCRβ+CD4+) and TCRγδ T cells (7AAD-CD45+CD3+TCRβ−TCRγδ+) were sorted from the pre-enriched CD90.2+ cell fraction.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
